Synthesis, structural characterisation and antibacterial activity of bis(1-phenyl-1,3-butanedionato)non-oxovanadium(IV) hydroxamates

References

• Butler A, Carrano CJ. Coordination chemistry of vanadium in biological system. Coord Chem Rev 1991; 109:61–105.
   Google Scholar
• Sutradhar M, Mukherjee G, Drew MGB, Ghosh S. Simple general method of generating non-oxo, non-amavadine model octacoordinated vanadium(IV) complexes of some tetradentate ONNO chelating ligands from various oxovanadium(IV/V) compounds and structural characterization of one of them. Inorg Chem 2007;46:5069–5075.
   PubMed Web of Science ®Google Scholar
• Sharma N, Meena Thakur, M, Kumar V, Chaudhry SC. Synthesis and characterization of non-oxovanadium(IV) complexes of biphenylphenols. Ind Chem 2008;47A:685–689.
   Google Scholar
• Kehl H, ed. Chemistry and Biology of Hydroxamic Acids, NY, Karger S, 1982:6
   Google Scholar
• Köster B. ABC transporter-mediated uptake of iron, siderophores, heme and vitamin B12. Res Microbiol 2001;152:291–301.
   Google Scholar
• Arnold M, Brown DA, Degg O, Errington W, Hasse W, Herlihy K, Kemp TJ, Nimir H, Werner R. Hydroxamate-bridged dinuclear nickel complexes as models for urease inhibition. Inorg Chem 1998;37:2920–2925.
   Web of Science ®Google Scholar
• Botos I, Scapozza L, Zhang D, Liotta LA, Meyer EF. Batimastat, a protein matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding. Proc Nat Acad Sci USA 1996;93:2749–2754.
   PubMed Web of Science ®Google Scholar
• Miller MJ. Synthesis and therapeutic potential of hydroxamic acid based siderophores and analogs. Chem Rev 1989;89:1563–1579.
   Web of Science ®Google Scholar
• Dixon NE, Hinds JA, Fihelly AK, Gazzola C, Winzor DJ, Blakeley RL, Zerner B. The molecular size and the mechanism of inhibition by hydroxamic acids. Spectrophotometric titrations of enzymes with reversible inhibitors. Canad J Biochem 1980;58:1323–1334.
   PubMedGoogle Scholar
• Wilker SH, Prescott JM. Stereospecificity of amino acid hydroxamate inhibition of aminopeptidases. J Biol Chem 1983;258:13517–13521.
   PubMed Web of Science ®Google Scholar
• Baker JO, Wilkes SH, Bayliss ME, Prescott JM. Hydroxamates and aliphatic boronic acids: marker inhibitors for aminopeptidase. Biochemistry 1983;22:2098–2103.
   PubMed Web of Science ®Google Scholar
• Kurzak B, Kozlowski H, Farkas E. Hydroxamic and aminohydroxamic acids and their complexes with metal ions. Coord Chem Rev 1992;114:169–200.
   Web of Science ®Google Scholar
• Boukhris S, Souizi A, Robert A. One-pot synthesis of α-chlorohydroxamic acids using gem dicyano epoxides. Tetrahed Lett 1996;37:179–182.
   Web of Science ®Google Scholar
• Schrami J, Tkallecová M, Pataridis S, Soukupová L, Blchta V, Roithová J, Exner O. Ring-substituted benzohydroxamic acids: 1H, 13C and 15N NMR spectra and NHOH proton exchange. Magn Reso Chem 2005;43:535–542.
   PubMed Web of Science ®Google Scholar
• Salmon L, Prost E, Merienne C, Hardré R, Morgant G. A convenient preparation of aldonohydroxamic acids in water and crystal structure of l-erythronohydroxamic acid. Carbohydr Res 2001;335:195–204.
   PubMed Web of Science ®Google Scholar
• Santana MD, Garcia G, Peréz J, Molinis E, López G. Mononuclear hydroxamate five-coordinate nickel(II) complexes: structural and spectroscopic characterization. Inorg Chem 2001;40:5701–5703.
   PubMed Web of Science ®Google Scholar
• Marmion CJ, Griffith D, Nolan KB. Hydroxamic acids–an intriguing family of enzyme inhibitors and biomedical ligands. Eur J Inorg Chem 2004;3003–3016.
   Web of Science ®Google Scholar
• Banerjee TK, Brahma SK, Bag SP. Synthesis and spectroscopic studies of vanadium(IV) hydroxamates and their mixed ligated derivatives. Ind J Chem 1993;32A:776–780.
   Google Scholar
• Banerjee TK, Brahma SK, Bag SP. Studies on some simple and mixed ligated oxovanadium(V) complexes of hydroxamic acids. Ind J Chem 1992;31A:202–204.
   Google Scholar
• Fisher DC, Barclay-Peet SJ, Balfe CA, Raymond KN. Synthesis and characterization of vanadium (V) and -(IV) hydroxamate complexes. X-ray crystal structures of oxochlorobis(benzohydroxamato)vanadium(V) and oxoisopropoxo(N,N’-dihydroxy-N,N’-diisopropylheptanediamido)vanadium(V). Inorg Chem 1989;28:4399–4403.
   Web of Science ®Google Scholar
• Shechter Y, Fridkin M, Gold Washer I, Gershonov E. Vanadium compounds in the treatment of elevated blood sugar levels US Patent 5888993, 2002.
   Google Scholar
• Maurya MR. Development of the coordination chemistry of vanadium through bis(acetylacetonato)oxovanadium(IV): synthesis, reactivity and structural aspects. Coord Chem Rev 2003;237:163–181.
   Web of Science ®Google Scholar
• Sharma N, Kumari M, Kumar V, Chaudhry SC, Kanwar SS. Synthesis, characterization and antibacterial activity of vanadium (IV) complexes of hydroxamic acids. J Coord Chem 2010;63:176–184.
   Web of Science ®Google Scholar
• Rowe RA, Jones MM. Vanadium(IV)oxy(acetylacetonate); [Bis(2,4-pentandiono)oxovanadium(IV). Inorg Synth 1957;5:113–116.
   Google Scholar
• Hambley TW, Hawkins CJ, Kabanos TA. Synthetic, structural, and physical studies of tris(2,4pentanedionato)vanadium(IV) hexachloroantimonate(V) and tris(1-phenyl-1,3-butanedionato)vanadium (IV) hexachloroantimonate(V). Inorg Chem 1987;26:3740–3745.
   Web of Science ®Google Scholar
• Hauser CR, Renfrow WB. Benzohydroxamic acid. J Org Synth 1953;2:67.
   Google Scholar
• Mackie TJ, McCartney, Practical Medical Microbiology, Melbourne, Churchill Livingstone Press, 1989:696.
   Google Scholar
• Farkas E, Brown DA, Cittaro R, Glass WK. Metal complexes of glutamic acid-γ-hydroxamic acid (Glu- γ -ha) (N-hydroxyglutamine) in aqueous solution. J Chem Soc Dalton Trans 1993;2803–2807.
   Google Scholar
• Liu SX, Gao S. Synthesis, crystal structure and spectral properties of VO(acetylacetone)(benzoylhydrazone)(8-quinolinol). Polyhedron 1998;17:81–84.
   Web of Science ®Google Scholar
• Von Dreele RB, Fay RC. Octahedral vanadium(IV) complexes. Synthesis and stereochemistry of vanadium(IV) beta-diketonates. J Am Chem Soc 1972;94:7935–7936.
   Web of Science ®Google Scholar
• Paine TK, Weyhermuller T, Slep LD, Neese F, Bill E, Bothe E, Wieghardt K, Chaudhuri P. Nonoxovanadium(IV) and oxovanadium(V) complexes with mixed O, X, O-donor ligands (X = S, Se, P, or PO). Inorg Chem 2004;43:7324–7338.
   PubMed Web of Science ®Google Scholar
• Cooper SR, Koh YB, Raymond KN. Synthetic, structural, and physical studies of bis(triethylammonium) tris(catecholato)vanadate(IV), potassium bis(catecholato)oxovanadate(IV), and potassium tris(catecholato)vanadate (III). J Am Chem Soc 1982;104:5092–5102.
   Web of Science ®Google Scholar
• Auerbach U, DellsVedova BSPC, Wieghardt K, Nuber B, Weiss J. Synthesis and characterization of stable pseudo-octahedral tris-phenolato complexes of vanadium-(III), -(IV), and -(V). J Chem Commun 1990;1004.
   Web of Science ®Google Scholar
• CJ Hawkins, Kabanos TA. Synthesis and characterization of (catecholato)bis(.beta.-diketonato)vanadium(IV) complexes. Inorg Chem 1989;28:1084–1087.
   Web of Science ®Google Scholar
• Henderson W, Mcindoe JS. Mass Spectrometry of Inorganic and Organometallic Compounds. Chichester: John Wiley and Sons, 2005:147.
   Google Scholar
• Guilherme LR, Massabni AC, Cuin A, Oliveir LAA, Castellano EE, Heinrich TA, Costa-Neto CM. Synthesis, characterization, crystal structure, and biological studies of vanadium complexes with glycolic acid. J Coord Chem 2009;62:1561–1571.
   Web of Science ®Google Scholar
• Colak AT, Colak F, Yesilel OZ, Buyukgungor O. Synthesis, characterization, crystal structure and biological activities of supramolecular compounds of Mn(II) and Zn(II) with dipicolinic acid and 8-hydroxyquinoline. J Coord Chem 2009;62:1650–1660.
   Web of Science ®Google Scholar
• Yu LC, Tang ZL, Yi PG, Liu SL. Hydrothermal synthesis, crystal structures and antibacterial activities of two transition metal complexes with ciprofloxacin. J Coord Chem 2009;62:894–902.
   Web of Science ®Google Scholar
• Saha DK, Padhye S, Anson CE, Powell AK. Hydrothermal synthesis, crystal structure, spectroscopy, electrochemistry and antimycobacterial evaluation of the copper (II) ciprofloxacin complex: [Cu(cf)2(BF4)2]·6H2O. Inorg Chem Commun 2002;5:1022–1027.
   Web of Science ®Google Scholar
• Chohan ZH, Supuran CT, Scozzafava A. Metalloantibiotics: synthesis and antibacterial activity of cobalt(II), copper(II), nickel(II) and zinc(II) complexes of kefzol. J Enz Inhib Med Chem 2004;19:79–84.
   PubMed Web of Science ®Google Scholar
• Chohan ZH, Hassan MUI, Khan KM, Supuran CT. In-vitro antibacterial, antifungal and cytotoxic properties of sulfonamide-derived Schiff’s bases and their metal complexes. J Enz Inhib Med Chem 2005;20:183–188.
   PubMed Web of Science ®Google Scholar
• Vogel AI, A text book of quantitative inorganic analysis including elementary instrumental analysis. Longman, London, 1975:537.
   Google Scholar
• Figgis BN, Lewis J, , “The magnetochemistry of complex compounds” in Modern coordination chemistry, principles and methods. Lewis J, Wilkins RG, New York, 1964:415.
   Google Scholar